Clinical use of lithium salts: guide for users and prescribers

for the International Group for Studies of Lithium (IGSLi)(Harvard University), Leonardo Tondo(Dalhousie University), Martin Alda(Dalhousie University), Michael Bauer(Erasmus MC), Veerle Bergink(University of Toronto), Paul Grof(Dalhousie University), Tomáš Hájek(Dalhousie University), Ute Lewitka(Aalborg University Hospital), Rasmus Wentzer Licht(Dalhousie University), Mirko Manchia(Dalhousie University), B. Müller‐Oerlinghausen(Aalborg University Hospital), René Ernst Nielsen(Aalborg University Hospital), Marylou Selo(Sigmund Freud Privatuniversität Wien), Christian Simhandl(Sigmund Freud Privatuniversität Wien), Ross J. Baldessarini(Harvard University)
International Journal of Bipolar Disorders
July 22, 2019
Cited by 201Open Access
Full Text

Abstract

BACKGROUND: Lithium has been used clinically for 70 years, mainly to treat bipolar disorder. Competing treatments and exaggerated impressions about complexity and risks of lithium treatment have led to its declining use in some countries, encouraging this update about its safe clinical use. We conducted a nonsystematic review of recent research reports and developed consensus among international experts on the use of lithium to treat major mood disorders, aiming for a simple but authoritative guide for patients and prescribers. MAIN TEXT: We summarized recommendations concerning safe clinical use of lithium salts to treat major mood disorders, including indications, dosing, clinical monitoring, adverse effects and use in specific circumstances including during pregnancy and for the elderly. CONCLUSIONS: Lithium continues as the standard and most extensively evaluated treatment for bipolar disorder, especially for long-term prophylaxis.


Related Papers

No related papers found

Powered by citation graph analysis